Scinai Immunotherapeutics Ltd.
SCNI· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| EPS Diluted | $0.10 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Scinai Immunotherapeutics Ltd. · CIK 1611747 · Engraved from SEC EDGAR